People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

19 Dec 2014
Price Change (% chg)

CHF0.95 (+1.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Landolt, Pierre 

Brief Biography

Dr. Pierre Landolt, Ph.D., serves as Member of the Board of Directors at Novartis AG since 1996. He is Member of the Corporate Governance and Nomination Committee at the Company. From 1974 to 1976, he worked for Sandoz Brazil SA. In 1977, he acquired an agricultural estate in the semi-arid Northeast Region of Brazil and, over several years, converted it into a model farm in organic and biodynamic production. Since 1997, Dr. Landolt has been Associate and Chairman of AxialPar Ltda, Brazil, an investment company focused on sustainable development, with investments in fish farming, soybean for human consumption and organic vegetable. In 2000, he co-founded EcoCarbone SA, France, a company active in the design and development of carbon-sequestration processes in Asia, Africa, South America and Europe. In 2007, he co-founded Amazentis SA, Switzerland, a startup company active in the convergence space of medication and nutrition. He is a Member of the Board of Directors of Syngenta AG and a Partner with unlimited liabilities of the Swiss private bank Landolt & Cie. In Brazil, Dr. Landolt serves as President of the Instituto Fazenda Tamandua, the Instituto Estrela de Fomento ao Microcredito, AxialPar Ltda. and Moco Agropecuaria Ltda. In Switzerland, he is Chairman of Emasan AG and Vaucher Manufacture Fleurier SA, Vice Chairman of Parmigiani Fleurier SA, and is on the Board of the Syngenta Foundation for Sustainable Agriculture. He is Member of the Board of EcoCarbone SA, France, and Swiss Amazentis SA. He is also Vice Chairman of the Montreux Jazz Festival Foundation. Dr. Landolt graduated with a Bachelors degree in Law from the University of Paris-Assas.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
410,058 -- 21,349 431,407

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt


Joseph Jimenez


Ulrich Lehner


Harry Kirsch


Peter Kornicker


Felix Ehrat

As Of 30 Dec 2013
Search Stocks